Health

Cancer Researchers to Rock Buddy Guy’s Legends for One Night Only

Leave a comment


The CheckPoints Rockin’ for a Cure Fundraiser at Buddy Guy’s in Chicago

“Inspiring the next generation of cancer immunotherapy researchers has always been one of SITC’s main priorities,” said SITC President Patrick Hwu, MD. “The Forward Fund helps to ensure that the early career scientists of today develop the cancer treatments of tomorrow.”


MILWAUKEE (PRWEB)

The CheckPoints, the Society for Immunotherapy of Cancer’s (SITC) house band, return for a performance at Buddy Guy’s Legends on June 5. The band features thirteen cancer researchers including Nobel Prize recipient James P. Allison, PhD, Regental Professor and Chair of the Department of Immunology at The University of Texas MD Anderson Cancer Center.

The band, who had the opportunity to perform with Buddy Guy himself, is excited to be back on stage in Chicago. The show celebrates Cancer Immunotherapy Month (June) and the strides being made in immunotherapy research.

The CheckPoints Rockin’ for a Cure Fundraiser is the annual fundraiser for SITC’s Forward Fund. Established in 2012, the Forward Fund provides grants to early career scientists and financially supports programs that stimulate the future of the field of cancer immunotherapy through education and research.

“Inspiring the next generation of cancer immunotherapy researchers has always been one of SITC’s main priorities,” said SITC President Patrick Hwu, MD. “The Forward Fund helps to ensure that the early career scientists of today develop the cancer treatments of tomorrow.”

Members of The CheckPoints include:

  • James P. Allison, PhD, Regental Professor and Chair of the Department of Immunology, the University of Texas MD Anderson Cancer Center (harmonica);

  • Lisa Butterfield, PhD, Vice President at the Parker Institute of Cancer Immunotherapy and Adjunct Professor at the University of California San Francisco (vocals);

  • Anna Crosetti, student at UCSF Medical School (vocals);

  • Thomas F. Gajewski, MD, PhD, Professor, Immunology and Cancer Program Leader at the University of Chicago (lead guitar);

  • Rachel W. Humphrey, MD, (lead vocals);

  • Patrick Hwu, MD, President and CEO, Moffitt Cancer Center (keyboard);

  • Jason J. Luke, MD, FACP, Associate Professor of Medicine, UPMC (trumpet);

  • Russell Pachynski, MD, Associate Professor at Washington University School of Medicine (trombone);

  • Ferran Prat, PhD, Senior Vice President, Research Administration and Industry Relations at the University of Texas MD Anderson Cancer Center (saxophone);

  • Brad Reinfeld, student at Vanderbilt University School of Medicine (bass guitar);

  • Dirk Spitzer, PhD, Assistant Professor of Surgery at Washington University (drums);

  • John M. Timmerman, MD, Professor of Medicine at the University of California, Los Angeles (guitar); and

  • Jedd Wolchok, MD, PhD, Chief, Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center (sousaphone).

Since 2012, the SITC has awarded more than $5 million toward programs, grants and initiatives that support early career scientists through research and education.

A limited number of VIP tickets to The CheckPoints: Rockin’ for a Cure are available by calling Mindon Laue at 414-271-2456 or emailing mlaue@sitcancer.org.

General admission will be available at the door on a first-come, first-served basis. A minimum donation of $30 is suggested in support of the Forward Fund. Doors open at 8 p.m. The CheckPoints are scheduled to take the stage at 9 p.m.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.

Share article on social media or email:



Leave a Reply